Esomeprazole Magnesium | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Esomeprazole Magnesium
Canada

PharmaCompass Sponsored Ads

Contact Supplier

Granules Esomeprazole Magnesium

Contact Supplier

xyz-pharma-m-2025-01-27

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2025-01-20

Contact Supplier

Esomeprazole Magnesium

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

139 API Suppliers, 65 USDMF, 50 CEP/COS, 7 JDMF, 35 EU WC, 79 KDMF, 46 NDC API, 68 Listed Suppliers, $ API Reference Price

139 API Suppliers
65 USDMF
50 CEP/COS
7 JDMF
35 EU WC
79 KDMF
46 NDC API
68 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

963 FDF Dossiers, 96 FDA Orange Book, 464 Europe, 23 Canada, 146 Australia, 39 South Africa, 195 Listed Dossiers

963 FDF Dossiers
96 FDA Orange Book
464 Europe
23 Canada
146 Australia
39 South Africa
195 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED RELEASE;ORAL - EQ 20MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 40MG BASE, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 20MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 5MG BASE/PACKET, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED RELEASE;ORAL - EQ 20MG BASE
CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE
CAPSULE, DELAYED REL PELLETS;ORAL - EQ 40MG BASE
FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET
FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 20MG BASE/PACKET
FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE/PACKET
FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 5MG BASE/PACKET
TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 7 Evonik, 1 Rochem International Inc, 17 SPI Pharma, 2 Seqens, 8 DKSH, 6 Faran Shimi Pharmaceutical, 3 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 6 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Pramukh Pharmachem, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 30 BASF, 15 Corel Pharma Chem, 3 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 11 Gangwal Chemicals, 13 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 19 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

71 Coating Systems & Additives, 64 Fillers, Diluents & Binders, 42 Controlled & Modified Release, 32 Solubilizers, 31 Thickeners and Stabilizers, 28 Direct Compression, 26 Taste Masking, 25 Granulation, 20 Lubricants & Glidants, 20 Disintegrants & Superdisintegrants, 19 Film Formers & Plasticizers, 17 Chewable & Orodispersible Aids, 16 Topical, 16 Parenteral, 15 Co-Processed Excipients, 9 Emulsifying Agents, 9 Empty Capsules, 6 API Stability Enhancers, 5 Coloring Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

71 Coating Systems & Additives
64 Fillers, Diluents & Binders
42 Controlled & Modified Release
32 Solubilizers
31 Thickeners and Stabilizers
28 Direct Compression
26 Taste Masking
25 Granulation
20 Lubricants & Glidants
20 Disintegrants & Superdisintegrants
19 Film Formers & Plasticizers
17 Chewable & Orodispersible Aids
16 Topical
16 Parenteral
15 Co-Processed Excipients
9 Emulsifying Agents
9 Empty Capsules
6 API Stability Enhancers
5 Coloring Agents
4 Rheology Modifiers
4 Vegetarian Capsules
4 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 152 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
152 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 395 Finished Drug Prices, 16 Annual Reports

3 US Medicaid Prescriptions
395 Finished Drug Prices
16 Annual Reports

MARKET PLACE

67 APIs, 35 FDF Dossiers

67 APIs
35 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 44 Health Canada Patents

2 US Patents
44 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 1 USP, 21 Others

5 EDQM
1 USP
21 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 204 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

23 All

01 2APOTEX INC

02 3ASTRAZENECA CANADA INC

03 1GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC

04 2JAMP PHARMA CORPORATION

05 2MANTRA PHARMA INC

06 4MYLAN PHARMACEUTICALS ULC

07 2PRO DOC LIMITEE

08 1Pharmascience Inc.

09 2SIVEM PHARMACEUTICALS ULC

10 2SUN PHARMA CANADA INC

11 2XEDITON PHARMACEUTICALS INC

filter Active Ingredients Reset all filters

23 All

01 8ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)

02 14ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM)

03 1Esomeprazole Magnesium

filter Dosage Form Reset all filters

23 All

01 2CAPSULE (DELAYED RELEASE)

02 1GRANULES FOR SUSPENSION, DELAYED RELEASE

03 16TABLET (DELAYED-RELEASE)

04 4TABLET (IMMEDIATE AND DELAYED-RELEASE)

filter Brand Name Reset all filters

23 All

01 2APO-ESOMEPRAZOLE

02 6ESOMEPRAZOLE

03 2M-ESOMEPRAZOLE

04 2MYL-ESOMEPRAZOLE

05 2MYLAN-NAPROXEN/ESOMEPRAZOLE MR

06 1NEXIUM

07 1NEXIUM - 20MG

08 1NEXIUM - 40MG

09 1NEXIUM 24HR

10 1PMS-ESOMEPRAZOLE DR

11 2TARO-ESOMEPRAZOLE

12 2VIMOVO

Esomeprazole Magnesium

List of Suppliers

Product Main Page

01

ASTRAZENECA CANADA INC

Asia Pharma Expo

Not Confirmed

ASTRAZENECA CANADA INC

Asia Pharma Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)

Brand Name : NEXIUM - 20MG

Dosage Form : TABLET (DELAYED-RELEASE)

Dosage Strength : 20MG

Packaging : 14/28/100

Approval Date :

Application Number : 2244521

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ASTRAZENECA CANADA INC

Asia Pharma Expo

Not Confirmed

ASTRAZENECA CANADA INC

Asia Pharma Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)

Brand Name : NEXIUM - 40MG

Dosage Form : TABLET (DELAYED-RELEASE)

Dosage Strength : 40MG

Packaging : 7/14/28/56/100

Approval Date :

Application Number : 2244522

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ASTRAZENECA CANADA INC

Asia Pharma Expo

Not Confirmed

ASTRAZENECA CANADA INC

Asia Pharma Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry